Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)
Completed · Phase 3 · Has a placebo group
Conditions studied: Common Cold
In brief
The design and interpretation of randomized trials is intimately connected to the use of "placebo". The nature and magnitude of placebo effects, however, is very poorly understood. This study will assess and compare placebo effects and physician interaction effects within a community-acquired common cold model. The goal of this study is to assess two kinds of placebo affects and how physician interaction effects; 1. The effect of receiving blinded placebo, compared to no treatment; and 2. The effect of receiving open-label active Echinacea treatment compared to blinded active treatment.
Key facts
- Study ID
- NCT00065715
- Run by
- University of Wisconsin, Madison
- People needed
- 719
- Starts
- 2003-09-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2014-12-04
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Suspected or known cold
- At least one of the following cold symptoms:
- nasal discharge, nasal congestion, sneezing, or sore throat
- Enrolled in school, for children 12 to 17 years of age
You may not qualify if…
- Pregnancy;
- Symptom duration > 36 hrs
- Concurrent use of antibiotics, antivirals, nasal steroids, decongestants or antihistamines;
- Anticipated need for symptom-relieving meds during cold
- Autoimmune/deficiency disease
- History of allergic rhinitis with current eye itching/sneezing
- History of asthma w/current cough/SOB
- Prior study entry
- Allergy to Echinacea
Where it is running
- University of Wisconsin-Madison Department of Family Medicine — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.